<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               4 CONTRAINDICATIONS<BR>               <BR>                  ZIAGEN is contraindicated in patients with previously demonstrated hypersensitivity to abacavir or any other component of the products. NEVER restart ZIAGEN or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status [see Warnings and Precautions (5.1), Adverse Reactions (6)].<BR>                  ZIAGEN is contraindicated in patients with moderate or severe hepatic impairment.<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           Previously demonstrated hypersensitivity to abacavir. (4, 5.1)<BR>                           Moderate or severe hepatic impairment. (4)<BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>